haloperidol has been researched along with Agranulocytosis in 6 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Agranulocytosis: A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case reported here of Haloperidol-induced neutropenia demonstrates one of many important drug reactions to which the elderly may be predisposed." | 3.67 | Neuroleptic-induced neutropenia in the elderly. ( Andolsek, K; Hanlon, J; Jurivich, DA, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastiampillai, T | 1 |
| Dhillon, R | 1 |
| Mohindra, R | 1 |
| HAEFNER, H | 1 |
| KUTSCHER, I | 1 |
| Schiele, B | 1 |
| Pollmächer, T | 1 |
| Hinze-Selch, D | 1 |
| Mullington, J | 1 |
| Holsboer, F | 1 |
| Mahmood, T | 1 |
| Silverstone, T | 1 |
| Jurivich, DA | 1 |
| Hanlon, J | 1 |
| Andolsek, K | 1 |
1 review available for haloperidol and Agranulocytosis
| Article | Year |
|---|---|
[COMPLICATIONS DURING CLINICAL THERAPY WITH PSYCHOPHARMACA].
Topics: Agranulocytosis; Autonomic Nervous System Diseases; Chemical and Drug Induced Liver Injury; Chlorpro | 1964 |
1 trial available for haloperidol and Agranulocytosis
| Article | Year |
|---|---|
Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors.
Topics: Adult; Agranulocytosis; Clozapine; Female; Haloperidol; Humans; Male; Prospective Studies; Receptors | 1995 |
4 other studies available for haloperidol and Agranulocytosis
| Article | Year |
|---|---|
Exacerbation of tics secondary to clozapine therapy.
Topics: Agranulocytosis; Antipsychotic Agents; Clozapine; Disease Progression; Dose-Response Relationship, D | 2008 |
[Therapeutic profile of haloperidol].
Topics: Agranulocytosis; Antipsychotic Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug | 1980 |
Comments on "Clozapine treatment after agranulocytosis induced by classic neuroleptics".
Topics: Adult; Agranulocytosis; Antipsychotic Agents; Haloperidol; Humans; Male; Risperidone; Schizophrenia; | 1996 |
Neuroleptic-induced neutropenia in the elderly.
Topics: Aged; Agranulocytosis; Depressive Disorder; Female; Granulocytes; Haloperidol; Humans; Leukocyte Cou | 1987 |